AdSilico is a company focused on transforming medical device development through in silico trials and virtual patient populations. Using computational models, they simulate device safety and performance in digital representations of human anatomy and physiology. Their generative AI technology enables the creation of diverse, customizable virtual patients, facilitating early design validation, faster market entry, and optimized clinical trials. AdSilico aims to reduce costs, avoid patient harm, and support the inclusion of underrepresented populations in research. Their innovative approach accelerates R&D, providing valuable insights before human testing.